Monte Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.87M Buy
3,257
+90
+3% +$43.2K 0.6% 46
2026
Q1
$1.56M Buy
3,167
+199
+7% +$108K 0.55% 57
2025
Q4
$1.72M Buy
2,968
+29
+1% +$16.4K 0.64% 49
2025
Q3
$1.43M Buy
2,939
+67
+2% +$31.2K 0.52% 57
2025
Q2
$1.16M Buy
2,872
+127
+5% +$53.1K 0.45% 62
2025
Q1
$1.17M Buy
2,745
+475
+21% +$257K 0.51% 55
2024
Q4
$1.18M Buy
2,270
+57
+3% +$31.3K 0.51% 54
2024
Q3
$1.37M Buy
2,213
+58
+3% +$34.3K 0.57% 45
2024
Q2
$1.19M Buy
2,155
+61
+3% +$34.9K 0.53% 52
2024
Q1
$1.22M Buy
2,094
+28
+1% +$15.7K 0.53% 50
2023
Q4
$1.1M Buy
2,066
+134
+7% +$64.9K 0.51% 51
2023
Q3
$978K Buy
1,932
+20
+1% +$10.7K 0.49% 49
2023
Q2
$998K Buy
1,912
+488
+34% +$263K 0.49% 49
2023
Q1
$821K Buy
1,424
+74
+5% +$41.7K 0.43% 51
2022
Q4
$743K Buy
1,350
+159
+13% +$84.3K 0.38% 55
2022
Q3
$604K Buy
1,191
+331
+38% +$185K 0.37% 54
2022
Q2
$467K Buy
860
+291
+51% +$160K 0.27% 68
2022
Q1
$336K Buy
+569
New +$327K 0.18% 71

Other funds holding TMO

Monte Financial Group's TMO Position: Q2 2026 in Review

Monte Financial Group increased its Thermo Fisher Scientific (TMO) stake by 2.8% in Q2 2026, buying an estimated $43.2K and bringing the position to 3,257 shares worth $1.87M. The position accounts for 0.6% of the portfolio, ranked #46.

Monte Financial Group first reported a position in TMO in Q1 2022 and has held it in 18 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Monte Financial Group held 3,257 shares of Thermo Fisher Scientific worth $1.87M as of Q2 2026.
  • Monte Financial Group bought 90 Thermo Fisher Scientific shares in Q2 2026, an estimated $43.2K.
  • Thermo Fisher Scientific made up 0.6% of Monte Financial Group's portfolio in Q2 2026, its #46 holding.
  • Monte Financial Group first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 18 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Monte Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.